Chabner Colloquium

 

November 18, 2019
Boston, Massachusetts USA

 

Bruce Chabner

Founded by Dr. Bruce A. Chabner, this annual symposium, presented in joint partnership with the Massachusetts General Hospital Cancer Center, encourages dialogue among experts on topics that bring cancer biology to clinical application. The Chabner Colloquium is an intensive and thoughtful look at the potential for rational, collaborative drug development, tapping into the resources of government, pharmaceutical and biotech companies, and globally statured cancer centers of excellence.

Focusing on new targets and their interventions; strategies for profiling and selection of patients
for targeted drug trials; and biomarkers and animal models to guide clinical development, the entire drug development process is represented. The Chabner Colloquium provides a dialogue that influences trial design, hastens cancer drug development, and, long-term, will rationalize and lend efficiency to the practice of oncology.

Attendee Quote

Agenda

 

Session 1: Promising New Targets for Drug Discovery and Development
Moderator: Susan Bates, MD, Columbia University Cancer Center
7:45 am Bruce A. Chabner, MD
MGH Cancer Center, Harvard Medical School
Welcome and Introduction
8:00 am Amir Fathi, MD
MGH/Harvard Medical School
IDH Inhibition in Acute Myeloid Leukemia - Emergence of a New Therapeutic Era
8:45 am Benjamin Ebert, MD, PhD
Dana-Farber Cancer Institute
Clonal Hematopoiesis
9:30 am Mo Motamedi, PhD
MGH Cancer Center
Epigenetic Reversal of Chemotherapy Resistance in Cancers
10:15 am Break/Exhibits
Session 2: Junior Faculty Forum
Moderator: Antonio "Tito" Fojo, MD, PhD, Columbia University Cancer Center
10:30 am Aparna Parikh, MD
Massachusetts General Hospital
ctDNA, a Biomarker of Residual Disease and Tumor Response in Gastrointestinal Cancers
11:00 am Ben Drapkin, MD, PhD
MGH Cancer Center
Cross-resistance in Small Cell Lung Cancer
11:30 am Jessica J. Lin, MD
Massachusetts General Hospital
RET As a Target in Lung Cancer
12:00 pm Srinivas Vinod Saladi, PhD
Massachusetts Eye and Ear Infirmary, MGH, HMS, Broad Institute
Targeting SWI/SNF-Hippo Axis in Squamous Cancers
Luncheon 12:30 pm Lunch and Exhibits in Beacon Hill Ballroom
1:00 pm Bruce A. Chabner, MD
MGH Cancer Center, Harvard Medical School
Young Investigator Award Presentation
Tomohiro Nishijima, MD, Kyushu Cancer Center, Japa
1:15 pm Marcela Maus, MD, PhD
MGH Cancer Center
Keynote Address: Innovations in Cell Therapy

 

logos